Skip to main content

Table 1 Patient characteristics of group G and group GP before and after PS matching

From: Does the transfer of a poor quality embryo with a good quality embryo benefit poor prognosis patients?

Variable

Before matching

After matching

G (n = 4484)

GP (n = 553)

P

G(n = 520)

GP (n = 520)

P

Maternal age

30 [27–33]

30 [27–33]

0.327

30.5 [28–34]

30 [27–33]

0.235

Paternal age

32 [29–35]

32 [29–36]

0.001

32 [29–36]

32 [29–35]

0.991

Duration of infertility

3.2 [2–5]

4 [2–6]

0.014

3.75 [2–6]

4 [2–6]

0.805

BMI (kg/m2)

20.8 [19.2–22.4]

20.8 [19.31–22.5]

0.47

21 [19.23–22.6]

20.8 [19.3–22.6]

0.77

PCOS (%)

427 (9.5)

43 (7.8)

0.183

44 (8.5)

41 (7.9)

0.734

Endometriosis (%)

396 (8.8)

58 (10.5)

0.199

57 (11)

54 (10.4)

0.763

Tubal factor (%)

2952 (65.8)

348 (62.9)

0.175

317 (61)

329 (63.3)

0.443

Male factor (%)

827 (18.4)

108 (19.5)

0.535

110 (21.2)

101 (19.4)

0.488

Parity (%)

 0

3736 (83.3)

471 (85.2)

0.268

427 (82.1)

443 (85.2)

0.18

 ≥ 1

748 (16.7)

82 (14.8)

93 (17.9)

77 (14.8)

Gravidity (%)

 0

2281 (50.9)

288 (52.1)

0.706

272 (52.3)

270 (51.9)

0.977

 1

1185 (26.4)

137 (24.8)

126 (24.2)

129 (24.8)

 ≥ 2

1018 (22.7)

128 (23.1)

122 (23.5)

121 (23.3)

Baseline FSH

6.52 [5.61–7.6]

6.58 [5.77–7.77]

0.056

6.66 [5.69–7.68]

6.67 [5.78–7.82]

0.573

AFC

12 [8–16]

11 [8–15]

0.005

11 [8–15]

11 [8–15]

0.869

Ovarian stimulation (%)

 Non-Agonist

386 (8.6)

63 (11.4)

0.03

68 (13.1)

62 (11.9)

0.574

 Agonist

4098 (91.4)

490 (88.6)

452 (86.9)

458 (88.1)

Insemination (%)

 IVF

3264 (72.8)

386 (69.8)

0.137

352 (67.7)

362 (69.6)

0.504

 ICSI

1220 (27.2)

167 (30.2)

168 (32.3)

158 (30.4)

Endometrial thickness

8.5 [7.6–9.8]

8.7 [7.8–9.8]

0.031

8.7 [7.7–10]

8.6 [7.8–9.8]

0.961

No.of blastocyst vitrified

3 [1–5]

1 [0–2]

< 0.001

0 [0–2]

1 [0–2]

0.065

Cycles of ET (%)

 1

1872 (41.7)

66 (11.9)

< 0.001

60 (11.5)

66 (12.7)

0.488

 2

1800 (40.1)

236 (42.7)

217 (41.7)

230 (44.2)

 ≥ 3

812 (18.1)

251 (45.4)

243 (46.7)

224 (43.1)

Endometrial Preparation (%)

 NC

2158 (48.1)

234 (42.3)

< 0.001

212 (40.8)

224 (43.1)

0.726

 HRT

1644 (36.7)

142 (25.7)

148 (28.5)

139 (26.7)

 HRT with GnRHa

682 (15.2)

177 (32)

160 (30.8)

157 (30.2)

Day of blastocyst (%)

 Day5

4008 (89.4)

271 (49)

< 0.001

281 (54)

270 (51.9)

0.494

 Day6

476 (10.6)

282 (51)

239 (46)

250 (48.1)

FBT with TQE (%)

2100 (46.8)

103 (18.6)

< 0.001

109 (21)

100 (19.2)

0.486

  1. Data are presented as median [first quartile, third quartile] and n (%)
  2. PCOS Polycystic ovary syndrome, ET Embryo transfer, NC Natural cycle, HRT Hormone replacement therapy, FBT Frozen blastocyst transfer, TQE Top quality embryo, blastocysts graded as AA, AB and BA with expansion grade ≥ 4